校企联合研发抗癌新药新疗法,中医药将为世界带来更多礼物

2018-10-10 佚名 成都中医药大学官网

10月9日下午,成都中医药大学肿瘤研究所与毕晓普癌症研究所战略合作协议签字仪式暨毕晓普癌症研究所Logo发布会在该校温江校区举行。活动现场大咖云集,1989年诺贝尔生理学或医学奖获得者、美国科学院院士、美国艺术与科学院院士、英国皇家科学院院士毕晓普(J Michael Bishop)教授,苹果商标设计者简诺夫(Rob Janoff)先生,英国皇家科学院院士劳埃德(Robert Lloyd)教授,

10月9日下午,成都中医药大学肿瘤研究所与毕晓普癌症研究所战略合作协议签字仪式暨毕晓普癌症研究所Logo发布会在该校温江校区举行。

活动现场大咖云集,1989年诺贝尔生理学或医学奖获得者、美国科学院院士、美国艺术与科学院院士、英国皇家科学院院士毕晓普(J Michael Bishop)教授,苹果商标设计者简诺夫(Rob Janoff)先生,英国皇家科学院院士劳埃德(Robert Lloyd)教授,英国皇家科学院院士奈史密斯(James Naismith)教授,以及Exelixis公司企业营运执行阿夫塔布(Dana Aftab)副总裁、斯坦福大学肿瘤学研究所费尔舍(Dean Felsher)所长、犹他大学细胞反应及调控项目威尔姆(Alana Welm)主任、南京医科大学发育遗传系史蒂文(Steven)主任等重量级嘉宾专程前往成都中医药大学,见证中西医强强联合,开启防治癌症研究新篇章。

校长余曙光致欢迎辞。他介绍,癌症将成为21世纪死亡的首要因素,是世界各国提高预期寿命的最重要障碍,是当前人类最大的健康挑战之一。在癌症的百年研究历史中,手术治疗、化学治疗、放射线治疗、靶向治疗、免疫疗法等纷纷涌现,发现负性免疫调节治疗癌症疗法的美国和日本科学家还获得了2018年诺贝尔生理学或医学奖。中医药治疗也是癌症的特色疗法之一,具有与放、化疗结合,起减毒与增敏作用;可有效改善患者临床症状,提高生存质量;可有效提高肿瘤稳定率,延长生存时间;可有效改善患者免疫状态等特点和优势。

余曙光指出,成都中医药大学肿瘤研究所与毕晓普癌症研究所的合作签约是成都中医药大学实现科学发展、跨越发展进程中的一件大事和喜事,是加快推进“双一流”建设,实现中医药学术振兴的重要举措,必将有力地推动学校内涵建设的加速进步。

会上,临床医学院/附属医院副院长田理教授,毕晓普癌症研究所所长杨顿博士分别代表校企双方签署合作协议,校长余曙光为双方联合实验室授牌。成都中医药大学肿瘤研究所与毕晓普癌症研究所的合作将立足中国西部地区,把西南地区的药物植物资源、传统中医药与癌症基础及转化研究有机地整合起来,通过优势互补、合作创新,设计、发现和开发比传统癌症疗法更有效、副作用更少的突破性创新药物和疗法,造福更多的患者。

据成都中医药大学肿瘤研究所所长由凤鸣介绍,中医药在防治疾病方面的宏观指导有自身理论优势,西医在药物提取药性分析方面有现代科学技术优势,两者优势互补。正如屠呦呦青蒿素的发现与提取,当中医药搭乘现代科学发展的快车,一定会为世界带来更多“礼物”。

据了解,毕晓普癌症研究所是全球唯一以毕晓普教授名字命名的癌症治疗基础研究机构。毕晓普教授在80年代与瓦慕斯(Harold E. Varmus)教授合作,发现了第一个人类原癌基因C-Src。他们的发现解释了癌症如何从细胞正常基因的变化中形成,将癌症的研究引入了基因水平,他们提出的“致癌基因”成为癌症生物学探索过程中的里程碑。目前,毕晓普癌症研究所在细胞生物学、小分子RNAs 生物学、癌症基因生物学、癌症干细胞和精准抗癌医学等领域均有深入研究。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55522, encryptionId=1e61555223e, topicName=抗癌新药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6224143528, createdName=zhangmingxiang, createdTime=Thu Aug 29 22:19:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349213, encodeId=89a3349213ea, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:36:13 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349212, encodeId=868c349212c4, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:28:42 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300198, encodeId=b1d7130019883, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409686, encodeId=ef6e140968652, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554547, encodeId=0c6a155454e16, content=<a href='/topic/show?id=74e458559f5' target=_blank style='color:#2F92EE;'>#新疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58559, encryptionId=74e458559f5, topicName=新疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d03114536414, createdName=kcb074, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348853, encodeId=7c9c348853bd, content=中西医结合治疗,希望路越走越远, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Thu Oct 11 08:36:21 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348836, encodeId=a56a34883651, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Oct 11 07:32:26 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049561, encodeId=2ea7104956192, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Thu Oct 11 02:19:00 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55522, encryptionId=1e61555223e, topicName=抗癌新药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6224143528, createdName=zhangmingxiang, createdTime=Thu Aug 29 22:19:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349213, encodeId=89a3349213ea, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:36:13 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349212, encodeId=868c349212c4, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:28:42 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300198, encodeId=b1d7130019883, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409686, encodeId=ef6e140968652, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554547, encodeId=0c6a155454e16, content=<a href='/topic/show?id=74e458559f5' target=_blank style='color:#2F92EE;'>#新疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58559, encryptionId=74e458559f5, topicName=新疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d03114536414, createdName=kcb074, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348853, encodeId=7c9c348853bd, content=中西医结合治疗,希望路越走越远, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Thu Oct 11 08:36:21 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348836, encodeId=a56a34883651, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Oct 11 07:32:26 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049561, encodeId=2ea7104956192, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Thu Oct 11 02:19:00 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2018-10-13 0328

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55522, encryptionId=1e61555223e, topicName=抗癌新药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6224143528, createdName=zhangmingxiang, createdTime=Thu Aug 29 22:19:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349213, encodeId=89a3349213ea, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:36:13 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349212, encodeId=868c349212c4, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:28:42 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300198, encodeId=b1d7130019883, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409686, encodeId=ef6e140968652, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554547, encodeId=0c6a155454e16, content=<a href='/topic/show?id=74e458559f5' target=_blank style='color:#2F92EE;'>#新疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58559, encryptionId=74e458559f5, topicName=新疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d03114536414, createdName=kcb074, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348853, encodeId=7c9c348853bd, content=中西医结合治疗,希望路越走越远, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Thu Oct 11 08:36:21 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348836, encodeId=a56a34883651, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Oct 11 07:32:26 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049561, encodeId=2ea7104956192, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Thu Oct 11 02:19:00 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2018-10-13 0328

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55522, encryptionId=1e61555223e, topicName=抗癌新药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6224143528, createdName=zhangmingxiang, createdTime=Thu Aug 29 22:19:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349213, encodeId=89a3349213ea, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:36:13 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349212, encodeId=868c349212c4, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:28:42 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300198, encodeId=b1d7130019883, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409686, encodeId=ef6e140968652, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554547, encodeId=0c6a155454e16, content=<a href='/topic/show?id=74e458559f5' target=_blank style='color:#2F92EE;'>#新疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58559, encryptionId=74e458559f5, topicName=新疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d03114536414, createdName=kcb074, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348853, encodeId=7c9c348853bd, content=中西医结合治疗,希望路越走越远, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Thu Oct 11 08:36:21 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348836, encodeId=a56a34883651, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Oct 11 07:32:26 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049561, encodeId=2ea7104956192, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Thu Oct 11 02:19:00 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2018-10-12 lqvr
  5. [GetPortalCommentsPageByObjectIdResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55522, encryptionId=1e61555223e, topicName=抗癌新药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6224143528, createdName=zhangmingxiang, createdTime=Thu Aug 29 22:19:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349213, encodeId=89a3349213ea, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:36:13 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349212, encodeId=868c349212c4, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:28:42 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300198, encodeId=b1d7130019883, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409686, encodeId=ef6e140968652, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554547, encodeId=0c6a155454e16, content=<a href='/topic/show?id=74e458559f5' target=_blank style='color:#2F92EE;'>#新疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58559, encryptionId=74e458559f5, topicName=新疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d03114536414, createdName=kcb074, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348853, encodeId=7c9c348853bd, content=中西医结合治疗,希望路越走越远, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Thu Oct 11 08:36:21 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348836, encodeId=a56a34883651, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Oct 11 07:32:26 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049561, encodeId=2ea7104956192, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Thu Oct 11 02:19:00 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2018-10-12 cathymary
  6. [GetPortalCommentsPageByObjectIdResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55522, encryptionId=1e61555223e, topicName=抗癌新药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6224143528, createdName=zhangmingxiang, createdTime=Thu Aug 29 22:19:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349213, encodeId=89a3349213ea, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:36:13 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349212, encodeId=868c349212c4, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:28:42 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300198, encodeId=b1d7130019883, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409686, encodeId=ef6e140968652, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554547, encodeId=0c6a155454e16, content=<a href='/topic/show?id=74e458559f5' target=_blank style='color:#2F92EE;'>#新疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58559, encryptionId=74e458559f5, topicName=新疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d03114536414, createdName=kcb074, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348853, encodeId=7c9c348853bd, content=中西医结合治疗,希望路越走越远, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Thu Oct 11 08:36:21 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348836, encodeId=a56a34883651, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Oct 11 07:32:26 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049561, encodeId=2ea7104956192, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Thu Oct 11 02:19:00 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2018-10-12 kcb074
  7. [GetPortalCommentsPageByObjectIdResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55522, encryptionId=1e61555223e, topicName=抗癌新药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6224143528, createdName=zhangmingxiang, createdTime=Thu Aug 29 22:19:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349213, encodeId=89a3349213ea, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:36:13 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349212, encodeId=868c349212c4, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:28:42 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300198, encodeId=b1d7130019883, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409686, encodeId=ef6e140968652, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554547, encodeId=0c6a155454e16, content=<a href='/topic/show?id=74e458559f5' target=_blank style='color:#2F92EE;'>#新疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58559, encryptionId=74e458559f5, topicName=新疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d03114536414, createdName=kcb074, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348853, encodeId=7c9c348853bd, content=中西医结合治疗,希望路越走越远, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Thu Oct 11 08:36:21 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348836, encodeId=a56a34883651, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Oct 11 07:32:26 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049561, encodeId=2ea7104956192, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Thu Oct 11 02:19:00 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2018-10-11 tw007007

    中西医结合治疗,希望路越走越远

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55522, encryptionId=1e61555223e, topicName=抗癌新药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6224143528, createdName=zhangmingxiang, createdTime=Thu Aug 29 22:19:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349213, encodeId=89a3349213ea, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:36:13 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349212, encodeId=868c349212c4, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:28:42 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300198, encodeId=b1d7130019883, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409686, encodeId=ef6e140968652, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554547, encodeId=0c6a155454e16, content=<a href='/topic/show?id=74e458559f5' target=_blank style='color:#2F92EE;'>#新疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58559, encryptionId=74e458559f5, topicName=新疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d03114536414, createdName=kcb074, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348853, encodeId=7c9c348853bd, content=中西医结合治疗,希望路越走越远, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Thu Oct 11 08:36:21 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348836, encodeId=a56a34883651, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Oct 11 07:32:26 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049561, encodeId=2ea7104956192, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Thu Oct 11 02:19:00 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2018-10-11 kafei

    了解一下谢谢

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55522, encryptionId=1e61555223e, topicName=抗癌新药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6224143528, createdName=zhangmingxiang, createdTime=Thu Aug 29 22:19:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349213, encodeId=89a3349213ea, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:36:13 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349212, encodeId=868c349212c4, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cOqHzStYzAhk1p39jXRFiaQFmcXbP22JGQ18oNLn8onu3v7icJqef4PicFBHJq7iacRLB1icKyWrPKUauOfO4tXqObg/132, createdBy=72221689804, createdName=0328, createdTime=Sat Oct 13 23:28:42 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300198, encodeId=b1d7130019883, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409686, encodeId=ef6e140968652, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554547, encodeId=0c6a155454e16, content=<a href='/topic/show?id=74e458559f5' target=_blank style='color:#2F92EE;'>#新疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58559, encryptionId=74e458559f5, topicName=新疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d03114536414, createdName=kcb074, createdTime=Fri Oct 12 14:19:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348853, encodeId=7c9c348853bd, content=中西医结合治疗,希望路越走越远, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Thu Oct 11 08:36:21 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348836, encodeId=a56a34883651, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Oct 11 07:32:26 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049561, encodeId=2ea7104956192, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Thu Oct 11 02:19:00 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2018-10-11 运动yd

    中医中药,大多被人诋毁,不过梅斯里总是客观公正的

    0

相关资讯

Nature:“神药”二甲双胍登上Nature!中国科学家首次揭示糖尿病患者为何易患癌

流行病学研究表明,糖尿病与癌症风险的增加息息相关。高葡萄糖水平可能是导致糖尿病和癌症关联的主要因素,但是我们对其中的分子机制知之甚少。近日,复旦大学生物医学研究院的施扬教授和石雨江教授合作的一项重大科研成果为这一问题带来了解释。

抗癌纳米材料多级载药系统令药物定向进入肿瘤深层

浙江大学转化医学院的一间实验室里,科学家用近红外激光照射乳腺癌小鼠。3分钟后,等候在肿瘤部位的“药匣子”打开,抗肿瘤药物快速均匀地渗透到肿瘤深层组织。4小时后,肿瘤细胞陆续凋亡。

抗癌神药!Keytruda获批在中国上市

2018年7月25日,默沙东PD-1单抗Keytruda(帕博利珠单抗注射液)的上市申请正式获得国家药品监督管理局的批准,用于黑色素瘤治疗。从2018年2月11日中国食品药品监督局(CFDA)受理申请到获批,不到6个月的时间创造了药物审批上市新的记录。它也成为继2018年6月15日百时美施贵宝Opdivo之后第2个获批在中国上市的PD-1/PD-L1单抗类药物。首个不分肿瘤类别的抗癌药物Keyt

Sci Immunol:T细胞的“特殊功能”能够提高抗癌效果!

目前最为全面且疗效最好的疫苗主要用于人们对于细菌、真菌和病毒的感染,但并不是所有的抗毒疫苗均能够有效减毒,以此使患者能够安全的使用这些的疫苗。来自科罗拉多大学Anschutz医学校区的科学家发现,疫苗引发的抗病T细胞不需要葡萄糖供能便可实现来抗毒T细胞的快速增殖,进而有效曾强特异性抗原的免疫反应,这一发现对肿瘤患者免疫治疗的发展具有重要意义。该研究的最新进展发表于最新的《ScienceI Im

Mol Cell:华人科学家首次发现二甲双胍可降解PD-L1,解除癌细胞对免疫细胞的压制,提高抗癌能力

本周《分子细胞》杂志上刊登了MD Anderson癌症中心华人学者洪明奇(Mien-Chie Hung)团队的最新研究成果,二甲双胍竟然能够导致癌细胞表达的PD-L1降解,避免它们“逃脱”免疫系统的“搜查”!

抗癌药价穿底!浙江要求平均降幅的60%以上

浙江省征求抗癌药专项集中采购方案,对于已在线交易的产品以交易价格为基础,按照其降税幅度(不少于4%)设定参考价,报价低于参考价且报价降幅大于等于平均降幅的60%,即为拟中标,否则将停止其在线交易资格。报价同时不得高于全国(除广东、福建、重庆、军区外)以省级最低价。要求严格执行“两票制”。9月25日,浙江省发布抗癌药专项集中采购工作方案,并向社会公开征求意见。要求在2018年底前完成专项集中采购工